A Prospective Multicenter Trial of the Efficacy and Tolerability of Neoadjuvant Sunitinib for Inoperable Metastatic Renal Cell Carcinoma

This study aimed to evaluate the efficacy, safety, and tolerability of 2-cycled neoadjuvant sunitinib therapy (NST) in patients with inoperable metastatic renal cell carcinoma (mRCC). Between 2009 and 2012, 14 patients with inoperable mRCC from 5 Korean academic centers were prospectively enrolled a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Han, Seo, Seong Il, Lee, Hyun Moo, Choi, Han-Yong, Jeon, Seung Hyun, Lee, Hyung-Lae, Kwon, Tae Gyun, Kim, Yong-June, Kim, Wun-Jae, Chung, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102864/
https://www.ncbi.nlm.nih.gov/pubmed/27822939
http://dx.doi.org/10.3346/jkms.2016.31.12.1983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102864/
https://www.ncbi.nlm.nih.gov/pubmed/27822939
http://dx.doi.org/10.3346/jkms.2016.31.12.1983

Ejemplares similares